ANI Pharmaceuticals intros generic Alinia

ANI Pharmaceuticals is introducing nitazoxanide tablets, 500 mg, which is the generic of Alinia.

The medication is used to treat diarrhea caused by certain parasites.

"The market launch of nitazoxanide tablets, another niche limited competition product, underscores our purpose of ‘Serving Patients, Improving Lives’,” said Nikhil Lalwani, president and CEO of ANI.

[Read more: ANI intros generic Trental]

 "We share ANI’s commitment to providing affordable, high-quality medicines for the patients who depend on them and are pleased to partner on the launch of this limited competition product,” said Jagadeesh Rangisetty, CEO of Biophore.

Nitazoxanide tablets had a market value of approximately $36.1 million, per December 2024 IQVIA data.

[Read more: ANI Pharmaceuticals receives ​​​​​​​FDA nod for generic Furadantin]